Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19
Yıl: 2021 Cilt: 3 Sayı: 3 Sayfa Aralığı: 220 - 224 Metin Dili: İngilizce DOI: 10.37990/medr.946543 İndeks Tarihi: 27-09-2022
Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19
Öz: Aim: The aim of the study is to investigate whether there is a correlation between the severity of pneumonia and fatty liver disease in COVID-19. Material and Method: In this study chest computed tomography (CT) images of 168 patients who were confirmed to be COVID-19 positive according to nasopharyngeal swab specimens were evaluated. The severity of pneumonia and the presence of hepatic steatosis were evaluated on CT images.Results: The patients were aged between 26 and 89, and the mean age was 63.6 ± 12.4 years. 101 (60.1%) of the patients were male. Hepatic steatosis was observed in 51 (30.4%) patients. No significant difference between the severity of pneumonia and hepatic steatosis on CT (p = 0.715) was found. No significant difference was found in the presence of hepatic steatosis in patients who died because of COVID-19 compared to patients who recovered (p = 0.938).Conclusion:This study revealed that there is no relationship between the severity of COVID-19 pneumonia and hepatic steatosis.
Anahtar Kelime: Covid-19’da Akciğer Tutulumu Şiddeti İle Yağlı Karaciğer Hastalığı Arasındaki İlişkilerin Değerlendirilmesi
Öz: Amaç: Çalışmanın amacı, COVID-19’da pnömoni şiddeti ile yağlı karaciğer hastalığı arasında korelasyon olup olmadığını araştırmaktır.Materyal ve Metot: Bu çalışmada nazofarengeal sürüntü örneklerine göre COVID-19 pozitif olduğu doğrulanan 168 hastanın göğüs bilgisayarlı tomografi (BT) görüntüleri değerlendirildi. BT görüntülerinde pnömoninin şiddeti ve hepatik steatoz varlığı değerlendirildi.Bulgular: Hastaların yaşları 26 ile 89 arasında olup, yaş ortalaması 63.6 ± 12.4 yıl idi. Hastaların 101’i (%60.1) erkekti. 51 (%30.4) hastada hepatik steatoz gözlendi. BT’de pnömoni şiddeti ile hepatik steatoz arasında anlamlı fark saptanmadı (p = 0.715). COVID-19 nedeniyle ölen hastalarda hepatik steatoz varlığında iyileşen hastalara göre anlamlı fark saptanmadı (p = 0.938).Sonuç: Bu çalışma, COVID-19 pnömonisinin şiddeti ile hepatik steatoz arasında bir ilişki olmadığını ortaya koymuştur.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus disease 2019 (COVID-19) CT Findings: A systematic review and meta- analysis. J Am Coll Radiol. 2020;17:701-9.
- 2. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) [Available from: https: // coronavirus. jhu. edu / map. Htm
- 3. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20.
- 4. T.C. Sağlık Bakanlığı, Covid-19 (SARS-CoV-2 Enfeksiyonu) Rehberi Bilim Kurulu Çalışması Ankara; 2020 [updated 14 Nisan 2020; cited 2020]. Available from: https://covid19 info. saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf.
- 5. Ji D, Qin E, Xu J, et al. Non-alcoholic fatty liver diseases in patients with COVID-19:A retrospective study. J Hepatol. 2020;73:451-3.
- 6. Fang Y, Zhang H, Xie J, et al. Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology. 2020;296:115—7.
- 7. Pan F, Ye T, Sun P, Gui S, et al. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19). Radiology. 2020;295:715–21.
- 8. Shereen MA, Khan S, Kazmi A, Bashir N, et al. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91-8.
- 9. Mendez IL, Matus JA, Gall SMB et all. Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19). Ann Hepatol. 2021;20:100271.
- 10. Hamer OW, Aguirre DA, Casola G, et al. Fatty liver: imaging patterns and pitfalls. Radiographics. 2006;26:1637-53.
- 11. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13.
- 12. Zadori N, Vancsa S, Farkas N, Hegyi P, , et al. The negative impact of comorbidities on the disease course of COVID-19. Intensive Care Med. 2020;46:1784-6.
- 13. Augusto Kreling Medeiros, Cinthia Callegari Barbisan, Italo Ribeiro Cruz et all. Higher frequency of hepatic steatosis at CT among COVID-19-positive patients. Abdominal Radiol. 2020;45:2748-54.
- 14. Schmita G, Lelotteb J, Vanhaebost J et al. The Liver in COVID- 19-Related Death: Protagonist or Innocent Bystander? Pathobiology. 2021;88:88-94.
- 15. Omrani-Nava V, Maleki I, Ahmadi A et al. Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients. Hepat Mon. 2020;20:103179.
- 16. Ridruejo E, Soza A. The liver in times of COVID-19: What hepatologists should know. Annals of Hepatology Volume 2020;19:353-8.
- 17. Forlano R, Mullish BH, Mukherjee SK, N, et al. Inhospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID19. PLoS ONE. 2020;15:e0240400.
| APA | ünlü s, Ilgar M, Akçiçek M (2021). Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. , 220 - 224. 10.37990/medr.946543 |
| Chicago | ünlü serkan,Ilgar Mehtap,Akçiçek Mehmet Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. (2021): 220 - 224. 10.37990/medr.946543 |
| MLA | ünlü serkan,Ilgar Mehtap,Akçiçek Mehmet Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. , 2021, ss.220 - 224. 10.37990/medr.946543 |
| AMA | ünlü s,Ilgar M,Akçiçek M Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. . 2021; 220 - 224. 10.37990/medr.946543 |
| Vancouver | ünlü s,Ilgar M,Akçiçek M Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. . 2021; 220 - 224. 10.37990/medr.946543 |
| IEEE | ünlü s,Ilgar M,Akçiçek M "Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19." , ss.220 - 224, 2021. 10.37990/medr.946543 |
| ISNAD | ünlü, serkan vd. "Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19". (2021), 220-224. https://doi.org/10.37990/medr.946543 |
| APA | ünlü s, Ilgar M, Akçiçek M (2021). Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. Medical records-international medical journal (Online), 3(3), 220 - 224. 10.37990/medr.946543 |
| Chicago | ünlü serkan,Ilgar Mehtap,Akçiçek Mehmet Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. Medical records-international medical journal (Online) 3, no.3 (2021): 220 - 224. 10.37990/medr.946543 |
| MLA | ünlü serkan,Ilgar Mehtap,Akçiçek Mehmet Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. Medical records-international medical journal (Online), vol.3, no.3, 2021, ss.220 - 224. 10.37990/medr.946543 |
| AMA | ünlü s,Ilgar M,Akçiçek M Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. Medical records-international medical journal (Online). 2021; 3(3): 220 - 224. 10.37990/medr.946543 |
| Vancouver | ünlü s,Ilgar M,Akçiçek M Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19. Medical records-international medical journal (Online). 2021; 3(3): 220 - 224. 10.37990/medr.946543 |
| IEEE | ünlü s,Ilgar M,Akçiçek M "Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19." Medical records-international medical journal (Online), 3, ss.220 - 224, 2021. 10.37990/medr.946543 |
| ISNAD | ünlü, serkan vd. "Evaluation of the Correlation Between the Severeness of Lung Involvement and Fatty Liver Disease in Covid-19". Medical records-international medical journal (Online) 3/3 (2021), 220-224. https://doi.org/10.37990/medr.946543 |
